TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 203 filers reported holding TANDEM DIABETES CARE INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $223,720 | -9.5% | 5,509 | +0.2% | 0.04% | -16.7% |
Q4 2022 | $247,135 | -24.2% | 5,498 | -0.3% | 0.05% | -26.0% |
Q2 2022 | $326,000 | -38.0% | 5,514 | +0.3% | 0.07% | -33.6% |
Q4 2020 | $526,000 | -15.7% | 5,498 | 0.0% | 0.11% | -27.6% |
Q3 2020 | $624,000 | +14.7% | 5,498 | 0.0% | 0.15% | +7.8% |
Q2 2020 | $544,000 | +53.7% | 5,498 | 0.0% | 0.14% | +22.6% |
Q1 2020 | $354,000 | +7.9% | 5,498 | 0.0% | 0.12% | +27.8% |
Q4 2019 | $328,000 | -3.8% | 5,498 | -4.9% | 0.09% | -13.5% |
Q3 2019 | $341,000 | -8.6% | 5,780 | 0.0% | 0.10% | -11.1% |
Q2 2019 | $373,000 | +1.6% | 5,780 | 0.0% | 0.12% | -12.7% |
Q1 2019 | $367,000 | +86.3% | 5,780 | +11.6% | 0.13% | +63.4% |
Q4 2018 | $197,000 | -23.0% | 5,180 | -13.2% | 0.08% | -11.8% |
Q3 2018 | $256,000 | +95.4% | 5,970 | 0.0% | 0.09% | +82.4% |
Q2 2018 | $131,000 | +336.7% | 5,970 | 0.0% | 0.05% | +325.0% |
Q1 2018 | $30,000 | +114.3% | 5,970 | 0.0% | 0.01% | +100.0% |
Q4 2017 | $14,000 | – | 5,970 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |